Patent classifications
C07C255/61
Organic electroluminescence device
An organic electroluminescence device including: an anode; one or more organic thin film layers including an emitting layer; a donor-containing layer; an acceptor-containing layer; and a light-transmissive cathode in this order, wherein the donor-containing layer comprises a compound represented by the following formula (I) or (II): ##STR00001##
Organic electroluminescence device
An organic electroluminescence device including: an anode; one or more organic thin film layers including an emitting layer; a donor-containing layer; an acceptor-containing layer; and a light-transmissive cathode in this order, wherein the donor-containing layer comprises a compound represented by the following formula (I) or (II): ##STR00001##
SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
The present invention includes substituted 3,3-bis(phenoxymethyl)-1,1-biphenyl compounds, analogues thereof, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient.
SUBSTITUTED 1,1'-BIPHENYL COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME
The present invention includes substituted 3,3-bis(phenoxymethyl)-1,1-biphenyl compounds, analogues thereof, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) and/or hepatitis D virus (HDV) infections in a patient.
ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES
Disclosed are organic compounds including a structure of formula (I-1). Also provided are mixtures containing the organic compounds, and at least one organic functional material. Further provided are organic electronic devices containing a functional layer, the functional layer comprises the organic compounds. The present disclosure can achieve better device performance through device structure optimization, especially to achieve high-performance OLED devices, which provides better material and preparation technology options for full-color display and lighting applications.
ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN ORGANIC ELECTRONIC DEVICES
Disclosed are organic compounds including a structure of formula (I-1). Also provided are mixtures containing the organic compounds, and at least one organic functional material. Further provided are organic electronic devices containing a functional layer, the functional layer comprises the organic compounds. The present disclosure can achieve better device performance through device structure optimization, especially to achieve high-performance OLED devices, which provides better material and preparation technology options for full-color display and lighting applications.
SYNTHESIS OF AN ANTIVIRAL COMPOUND
- Amy Cagulada ,
- Johann Chan ,
- Lina Chan ,
- Denise A. Colby ,
- Kapil Kumar Karki ,
- Darryl Kato ,
- Katie Ann Keaton ,
- Sudha Kondapally ,
- Christopher Levins ,
- Adam Littke ,
- Ruben Martinez ,
- Dominika Pcion ,
- Troy Reynolds ,
- Bruce Ross ,
- Michael Sangi ,
- Adam J. Schrier ,
- Pamela Seng ,
- Dustin Siegel ,
- Nathan Shapiro ,
- Donald Tang ,
- James G. Taylor ,
- Jonathan Tripp ,
- Andrew W. Waltman ,
- Lawrence Yu
The present disclosure provides processes for the preparation of a compound of formula I:
##STR00001##
which is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.
SYNTHESIS OF AN ANTIVIRAL COMPOUND
- Amy Cagulada ,
- Johann Chan ,
- Lina Chan ,
- Denise A. Colby ,
- Kapil Kumar Karki ,
- Darryl Kato ,
- Katie Ann Keaton ,
- Sudha Kondapally ,
- Christopher Levins ,
- Adam Littke ,
- Ruben Martinez ,
- Dominika Pcion ,
- Troy Reynolds ,
- Bruce Ross ,
- Michael Sangi ,
- Adam J. Schrier ,
- Pamela Seng ,
- Dustin Siegel ,
- Nathan Shapiro ,
- Donald Tang ,
- James G. Taylor ,
- Jonathan Tripp ,
- Andrew W. Waltman ,
- Lawrence Yu
The present disclosure provides processes for the preparation of a compound of formula I:
##STR00001##
which is useful as an antiviral agent. The disclosure also provides compounds and processes for the preparation of the compounds that are synthetic intermediates to the compound of formula I.
MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.
MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF
The present invention provides compounds, compositions thereof, and methods of using the same.